Copyright
©The Author(s) 2016.
World J Clin Oncol. Oct 10, 2016; 7(5): 420-424
Published online Oct 10, 2016. doi: 10.5306/wjco.v7.i5.420
Published online Oct 10, 2016. doi: 10.5306/wjco.v7.i5.420
Female breast cancer | Male breast cancer | |
Epidemiology | Very common (125 new cases per 100000 women per year) | Very rare (1.2 new cases per 100000 men per year) |
Average age at diagnosis | 62 yr | 67 yr |
Diagnostics | Mammography, sonography; in selected cases MRI | Sonography; mammography if possible; in selected cases MRI |
Association with BRCA mutation | 5%-10% of all cases are BRCA-positive | 10%-20% of all cases are BRCA-positive |
Surgery | Breast-conserving surgery (70%-80% patients) or mastectomy; sentinel node biopsy in cN0 | Mastectomy; sentinel node biopsy in cN0 |
Reconstruction techniques | Implant or flap-based reconstruction after mastectomy | Flap-based reconstruction of thoracic wall in case of a large tumor |
Chemotherapy | Recommendation depends on tumor biology and tumor load; adjuvant or neoadjuvant use; usually anthracycline- and taxane-based | |
Endocrine therapy | Recommended in hormone receptor positive tumors; tamoxifen or aromatase inhibitor | Recommended in hormone receptor positive tumors; tamoxifen |
HER2-targeted treatment | Trastuzumab recommended in HER2-positive tumors | |
Radiation therapy | Thoracic wall or lymph node radiation in case of higher tumor load | |
Recommended after breast-conserving surgery; thoracic wall or lymph node radiation in case of higher tumor load |
- Citation: Banys-Paluchowski M, Burandt E, Banys J, Geist S, Sauter G, Krawczyk N, Paluchowski P. Male papillary breast cancer treated by wide resection and latissimus dorsi flap reconstruction: A case report and review of the literature. World J Clin Oncol 2016; 7(5): 420-424
- URL: https://www.wjgnet.com/2218-4333/full/v7/i5/420.htm
- DOI: https://dx.doi.org/10.5306/wjco.v7.i5.420